(S1 (S (S (NP (DT The) (NN semaphorin) (NN 7A) (NN receptor) (NN Plexin) (NN C1)) (VP (VBZ is) (VP (VBN lost) (PP (IN during) (NP (NN melanoma) (NN metastasis)))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN transformation)) (PP (IN of) (NP (NP (JJ normal) (NNS melanocytes)) (, ,) (CC or) (NP (NN melanocyte) (NN stem) (NNS cells)))) (, ,) (PP (TO to) (NP (NN melanoma))) (, ,)) (VP (VBZ is) (NP (NP (DT a) (JJ complex) (NN process)) (VP (VBG involving) (NP (JJ multiple) (NNS mechanisms)))))) (. .)))
(S1 (S (S (NP (NP (NN Loss)) (PP (IN of) (NP (NP (NN tumor) (NN suppressor) (NNS proteins)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP function) (PP (IN as) (NP (NP (NNS brakes)) (PP (IN on) (NP (NP (NN cell) (NN growth)) (, ,) (NP (NN migration)) (, ,) (CC or) (NP (NN cell) (NN survival))))))))) (, ,)))) (VP (VBD was) (VP (VBN recognized) (ADVP (RB early)) (PP (IN on)) (PP (IN as) (NP (NP (DT an) (JJ important) (NN mechanism)) (PP (IN for) (NP (NP (NP (NN initiation)) (CC and) (NP (NN progression))) (PP (IN of) (NP (NN melanoma)))))))))) (. .)))
(S1 (S (S (NP (NP (NNS Semaphorins)) (CC and) (NP (NP (PRP$ their) (JJ cognate) (NNS receptors)) (, ,) (NP (NP (NN Plexins)) (CC and) (NP (NN neuropilins))) (, ,))) (VP (VBP are) (VP (VBN involved) (PP (IN in) (NP (NP (JJ neuronal) (NN pathfinding)) (, ,) (NP (JJ immune) (NN function)) (, ,) (CC and) (NP (NP (NN tumor) (NN progression)) (PP (IN through) (NP (NP (NNS effects)) (PP (IN on) (NP (NP (NN blood) (NN vessel) (NN growth)) (CC and) (NP (NN cell) (NN migration)))))))))))) (. .)))
(S1 (S (S (S (NP (NP (NN Semaphorin) (NN 7A)) (PRN (-LRB- -LRB-) (NP (NN Sema7A)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ membrane-linked) (NN semaphorin)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN expressed) (PP (IN by) (NP (JJ human) (NNS keratinocytes)))))))))) (, ,) (CC and) (S (NP (PRP we)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN Sema7A)) (VP (VBZ binds) (PP (TO to) (NP (JJ human) (NNS melanocytes))) (PP (IN through) (NP (NP (NN beta1-integrins)) (CC and) (NP (DT the) (NN Plexin) (NN C1) (NN receptor))))))))))) (. .)))
(S1 (S (S (NP (JJ Functional) (NNS studies)) (VP (VBD showed) (SBAR (IN that) (S (NP (NN Sema7A)) (VP (VBZ stimulates) (NP (NP (JJ cytoskeletal) (NN reorganization)) (PP (IN in) (NP (JJ human) (NNS melanocytes)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NN adhesion)) (CC and) (NP (NN dendrite)) (NP (NN formation))))))))))) (. .)))
(S1 (S (S (NP (NP (JJ Downstream) (NNS targets)) (PP (IN of) (NP (NP (NN Plexin) (NN C1) (NN signaling)) (PP (IN in) (NP (JJ human) (NNS melanocytes)))))) (VP (VBP include) (NP (NP (NP (NN cofilin)) (CC and) (NP (NN LIM) (NN kinase) (CD II))) (, ,) (SBAR (WHNP (NP (DT both)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP are) (NP (NP (JJ critical) (NNS mediators)) (PP (IN of) (NP (NP (NN cell) (NN adhesion)) (CC and) (NP (NN migration))))))))))) (. .)))
(S1 (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP (PRP we)) (VP (VBD analyzed) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN Plexin) (NN C1)))) (S (VP (VBG using) (NP (NP (NN immunohistochemistry)) (PP (IN on) (NP (NP (NNS sections)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ primary)) (CC and) (ADJP (JJ matched))) (JJ metastatic) (NNS lesions)) (PP (PP (IN from) (NP (CD 19) (NNS subjects))) (CC and) (PP (IN in) (NP (DT a) (JJ large) (NN melanoma) (NN tumor) (NN microarray)))))))))))) (. .)))
(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP show) (NP (NP (DT a) (JJ significant) (NN loss)) (PP (IN of) (NP (NN Plexin) (NN C1))) (PP (IN in) (NP (JJ metastatic) (NN melanoma)))) (PP (VBN compared) (PP (IN with) (NP (JJ primary) (NN melanoma)))) (, ,) (S (VP (VBG suggesting) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (DT the) (NN Plexin) (NN C1) (NN receptor)) (VP (VBZ is) (NP (NP (DT a) (NN tumor) (NN suppressor) (NN protein)) (PP (IN for) (NP (NN melanoma)))))))))))) (. .)))
